Ionis Pharmaceuticals, Inc.
IONS
$55.28
-$0.74-1.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 8.88% | 21.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.88% | 21.03% | |||
| Cost of Revenue | -2.07% | -25.89% | |||
| Gross Profit | 79.76% | 139.08% | |||
| SG&A Expenses | 6.81% | 15.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.85% | -12.99% | |||
| Operating Income | 12.89% | 45.25% | |||
| Income Before Tax | -22.83% | 59.50% | |||
| Income Tax Expenses | 479.82% | -85.25% | |||
| Earnings from Continuing Operations | -23.90% | 59.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -23.90% | 59.66% | |||
| EBIT | 12.89% | 45.25% | |||
| EBITDA | 13.49% | 46.11% | |||
| EPS Basic | -23.50% | 60.37% | |||
| Normalized Basic EPS | 10.47% | 46.84% | |||
| EPS Diluted | -23.50% | 60.37% | |||
| Normalized Diluted EPS | 10.47% | 46.84% | |||
| Average Basic Shares Outstanding | 0.33% | 1.77% | |||
| Average Diluted Shares Outstanding | 0.33% | 1.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||